Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Molecular Pharmacology|November 1, 1987
In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29H Paris, M Taouis, J GalitzkyEuropean Journal of Pharmacology|February 25, 1991
A1 adenosine receptors in the human fat cell: tissue distribution and regulation of radioligand bindingD Larrouy, J Galitzky, M LafontanAnnales D'Endocrinologie|January 10, 2001
[Lipid mobilization and energy metabolism: impact of molecular and cellular approaches on the treatment of obesity]M Lafontan, M Berlan, J GalitzkyFundamental & Clinical Pharmacology|January 1, 1995
Beta 3-adrenoceptors in the cardiovascular systemM Berlan, J Galitzky, J L MontastrucMolecular Pharmacology|March 1, 1989
Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine bindingH Paris, J Galitzky, J M SenardThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002J Galitzky, D Larrouy, M Berlan, et al.The Journal of Clinical Investigation|May 1, 1993
Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissueJ Galitzky, M Lafontan, J Nordenström, et al.European Journal of Clinical Investigation|April 1, 1987
Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequencesP Mauriege, J Galitzky, M Berlan, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonistsJ Galitzky, P Mauriege, M Berlan, et al.Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1993
[Specific stimulation of adipose tissue adrenergic beta 3 receptors by octopamine]J Galitzky, C Carpene, M Lafontan, et al.Pageof 8